sulfamethoxazole has been researched along with Hodgkin Disease in 1 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, AR | 1 |
| Jackson, JM | 1 |
| Scopa, J | 1 |
| Lane, GK | 1 |
| Wilson, R | 1 |
1 other study available for sulfamethoxazole and Hodgkin Disease
| Article | Year |
|---|---|
Nocardiosis: diagnosis and management, with a report of three cases.
Topics: Adult; Cephaloridine; Folic Acid Antagonists; Hodgkin Disease; Humans; Lung Diseases; Male; Middle A | 1971 |